Navigation Links
Comprehensive Safety Tests Published on Ruyan(R) Smoking Alternatives
Date:10/28/2008

rom anyone claiming the right to market or sell similar products."

About the Products

The Ruyan V-8 E-cigarette is a sophisticated electronic device with patents granted in China and Europe and Patents Pending in the US. The device atomizes purified, liquid nicotine and produces a vapor that, when inhaled, satisfies a smoker's craving for tobacco. The vapor contains none of the harmful chemicals commonly found in traditional cigarette smoke and none of those chemicals considered poisonous or carcinogenic. When and if the vapor is expelled, it does not contain any of the harmful chemicals found in second hand smoke. Cartridges for the Ruyan E-cigarette are available in regular and menthol flavors. The Ruyan V-8 was named the most innovative new product at the 2008 Tobacco Plus Expo.

The Ruyan Vegas E-cigar comes in two varieties, the Classic, which contains 16 mg of nicotine, and the Freestyle, which is nicotine free. Both E-cigars produce a thick, flavorful vapor that satisfies a user's tobacco cravings. The Ruyan Vegas E-cigar was named the most marketable new product at the 2008 Tobacco Plus Expo.

Ruyan smoking alternatives do not produce tobacco smoke or smoke of any kind and, as such, do not violate smoking bans or restrictions. Users have successfully satisfied tobacco urges in all states and in all places where smoking is otherwise restricted.

About the Company

Ruyan America, Inc. is a U.S.-based joint venture partner of Ruyan Holdings, Ltd. of Hong Kong. Mr. Hon Lik, the inventor and patent holder of the E-cigarette and the atomizing technology that is critical to it, the E- cigar and the E-pipe, is the Vice-Chairman of Ruyan Holdings, Ltd. and the Chairman of Ruyan America. These products, varieties of replacement cartridges and their accessories are designed, manufactured and sold for the cigarette alternative/smoking substitution market. They allow smokers to satisfy their tobacco cravings in places and situations
'/>"/>

SOURCE Ruyan America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
2. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
3. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
9. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
10. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
11. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TheNetherlandsandJOHANNESBURG,November25/PRNewswir...sDiscoveryannouncedtoday,thattheyhavesignedacollab...ices. , Pyxis,sworldclasscomputationalchemist...ba,sservicedivisiontoprovidemedicinaland,synthetic...internationalclientnetwork.iThembaPharmaceuticalsa...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,In...tmentsforaorticdisorders,announcedtodaythatithasfi...patentinfringementlawsuitbroughtagainstitinOctober...istrictCourtinIndianapolis,Indiana. ,, Endologi...edStatesPatentandTrademarkOffice(USPTO)conductspro...
(Date:11/24/2009)...C,Md.,Nov.24/PRNewswire/--Inadditiontofamily,frien...ladelphiajurorstoherThanksgivinggratitudelist. ,...nkfultothem,"shesaidofMonday,sverdictstotaling$103... Wisneskiisamong12,000womennationwidewhohavesuedWy...apydrugsPremarinandPrempro.Wisneskiandtheothervict...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Maryland Woman Thankful for Wyeth Verdicts 2Swine Flu Shots Safe for People With Weak Immune Systems 3A Experts 57649 1Swine Flu Shots Safe for People With Weak Immune Systems 3A Experts 57649 2Swine Flu Shots Safe for People With Weak Immune Systems 3A Experts 57649 3Hot microbes cause groundwater cleanup rethink 9979 1Hot microbes cause groundwater cleanup rethink 9979 2Researchers prolong the half life of biopharmaceutical proteins 9974 1Researchers prolong the half life of biopharmaceutical proteins 9974 2
(Date:11/26/2009)...n Communications announces a highly effective and ...s struggling to make an economic recovery. , ...lu fears is the type of challenge that could send ...ing to Dr. David Benton, business growth expert an...tem – The Rfactor Intensive . “Fear...
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...swire-USNewswire/--TheBlackAIDSInstituterecentlyhe...ershipfor2010. ,, ThenewBoardMembersareahighlyd...law,finance,governmenthealthprograms,editorial,and...erangeofpersonalbackgroundsincludingbothheterosexu...es,andrepresentingmultipleagegroups. ,, (Photo:...
(Date:11/25/2009)...ular cancer who were treated with cisplatin-based ...ng neurological side effects and Raynaud-like phen...rapy, according to a new study published online No...nstitute . , Marianne Brydy, M.D., of the Depart...n Bergen, Norway, and colleagues conducted a cross...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...c.,(Pink Sheets: MEDQ.PK) today announced that it ...Q for the first two quarters of 2007 and expects,f...e Commission (SEC) by,the middle of October 2007. ... time since the filing of its Form,10-Q for the th...
... lives of patients who have suffered a stroke and ...o a study published on bmj.com today. , Stroke ...and the leading cause of serious, long-term disabi...g, dressing and going to the toilet. We already k...
...as the elderly and people with physical or mental ...n assisted death are not supported by evidence, sa...ted death (both voluntary active euthanasia and ph...uicide was also legalised in Oregon in 1997, write...
... for a $100 million initiative to create an instit...lth problems in the developing world, such as HIV/...nced today during the annual meeting of the Clinto..., with the goal of establishing an institute that ...
...completion, SAN FRANCISCO, Sept. 28 Inspired fat...five-month 2,200-mile fundraising journey to,the G...n San Francisco,Calif., two weeks ahead of schedul...y 19 years. Among centers serving the development...
...on,Pharmaceuticals LLC, a clinical-stage drug deve...gs utilizing a novel mechanism of action,that enha... of a Phase I,safety trial of its lead drug candid... support the company,s overall growth,and advance ...
Other Medicine News:Health News:MedQuist Updates Status of Outstanding SEC Filings 2Health News:Vulnerable groups are not at higher risk of physician-assisted death 2Health News:Rice unveils $100 million initiative for world health technology 2Health News:Rice unveils $100 million initiative for world health technology 3Health News:Man Walking to California for Son Approaching Finish Line 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 3Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 4
Avant E-Z Rack Premium Low Binding Microreach Pipet Tips
Finntip Wide 100-1000 L
Finntip 250 Universal Refill Pack
MBP 200G Genomic Tip
Medicine Products: